Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen

Chuang C. Chiueh, Sang Lee, Tsugunobu Andoh, Dennis L. Murphy

Research output: Contribution to journalReview article

48 Citations (Scopus)

Abstract

The original neuroprotective hypothesis of estrogen was based on the gender difference in brain response to the ischemia-reperfusion injury. Additional clinical reports also suggest that estrogen may improve cognition in patients with Alzheimer disease. 17β-Estradiol is the most potent endogenous ligand of estrogen, which protects against neurodegeneration in both cell and animal models. Estrogen-mediated neuroprotection is probably mediated by both receptor-dependent and -independent mechanisms. Binding of estrogen such as 17β-estradiol to estrogen receptors (ERs) activates the homodimers of ER-DNA and its binding to estrogen response elements in the promoter region of genes such as neuronal nitric oxide synthase (NOS1) for regulating gene expression in target brain cells. In addition to the induction of NOS1, estrogen increases the expression of antiapoptotic protein such as bcl-2. Furthermore, our recent observations provide new molecular biologic and pharmacologic evidence suggesting that physiologic concentrations of 17β-estradiol (<10 nM) activate ERs (ERβ > ERα) and upregulate a cyclic guanosine 5′-monophosphate (cGMP)-dependent thioredoxin (Trx) and MnSOD expression following the induction of NOS1 in human brain-derived SH-SY5Y cells. We thus proposed that the estrogen-mediated gene induction of Trx plays a pivotal role in the promotion of neuroprotection because Trx is a multifunctional antioxidative and antiapoptotic protein. For managing progressive neurodegeneration such as Alzheimer dementia, our estrogen proposal of the signaling pathway of cGMP-dependent protein kinase (PKG) in mediating estrogen-induced cytoprotective genes thus fosters research and development of the new estrogen ligands devoid of female hormonal side effects such as carcinogenesis.

Original languageEnglish (US)
Pages (from-to)27-31
Number of pages5
JournalEndocrine
Volume21
Issue number1
DOIs
StatePublished - Jun 1 2003

Fingerprint

Thioredoxins
Estrogens
Guanosine Monophosphate
Estradiol
Estrogen Receptors
Alzheimer Disease
Brain
Genes
Ligands
Cyclic GMP-Dependent Protein Kinases
Nitric Oxide Synthase Type I
Response Elements
Reperfusion Injury
Genetic Promoter Regions
Cognition
Carcinogenesis
Proteins
Up-Regulation
Animal Models

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Chiueh, Chuang C. ; Lee, Sang ; Andoh, Tsugunobu ; Murphy, Dennis L. / Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. In: Endocrine. 2003 ; Vol. 21, No. 1. pp. 27-31.
@article{eb5e8dab1b6744bf81a6f78642dfb9cb,
title = "Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen",
abstract = "The original neuroprotective hypothesis of estrogen was based on the gender difference in brain response to the ischemia-reperfusion injury. Additional clinical reports also suggest that estrogen may improve cognition in patients with Alzheimer disease. 17β-Estradiol is the most potent endogenous ligand of estrogen, which protects against neurodegeneration in both cell and animal models. Estrogen-mediated neuroprotection is probably mediated by both receptor-dependent and -independent mechanisms. Binding of estrogen such as 17β-estradiol to estrogen receptors (ERs) activates the homodimers of ER-DNA and its binding to estrogen response elements in the promoter region of genes such as neuronal nitric oxide synthase (NOS1) for regulating gene expression in target brain cells. In addition to the induction of NOS1, estrogen increases the expression of antiapoptotic protein such as bcl-2. Furthermore, our recent observations provide new molecular biologic and pharmacologic evidence suggesting that physiologic concentrations of 17β-estradiol (<10 nM) activate ERs (ERβ > ERα) and upregulate a cyclic guanosine 5′-monophosphate (cGMP)-dependent thioredoxin (Trx) and MnSOD expression following the induction of NOS1 in human brain-derived SH-SY5Y cells. We thus proposed that the estrogen-mediated gene induction of Trx plays a pivotal role in the promotion of neuroprotection because Trx is a multifunctional antioxidative and antiapoptotic protein. For managing progressive neurodegeneration such as Alzheimer dementia, our estrogen proposal of the signaling pathway of cGMP-dependent protein kinase (PKG) in mediating estrogen-induced cytoprotective genes thus fosters research and development of the new estrogen ligands devoid of female hormonal side effects such as carcinogenesis.",
author = "Chiueh, {Chuang C.} and Sang Lee and Tsugunobu Andoh and Murphy, {Dennis L.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1385/ENDO:21:1:27",
language = "English (US)",
volume = "21",
pages = "27--31",
journal = "Endocrine",
issn = "0969-711X",
publisher = "Humana Press",
number = "1",

}

Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. / Chiueh, Chuang C.; Lee, Sang; Andoh, Tsugunobu; Murphy, Dennis L.

In: Endocrine, Vol. 21, No. 1, 01.06.2003, p. 27-31.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen

AU - Chiueh, Chuang C.

AU - Lee, Sang

AU - Andoh, Tsugunobu

AU - Murphy, Dennis L.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - The original neuroprotective hypothesis of estrogen was based on the gender difference in brain response to the ischemia-reperfusion injury. Additional clinical reports also suggest that estrogen may improve cognition in patients with Alzheimer disease. 17β-Estradiol is the most potent endogenous ligand of estrogen, which protects against neurodegeneration in both cell and animal models. Estrogen-mediated neuroprotection is probably mediated by both receptor-dependent and -independent mechanisms. Binding of estrogen such as 17β-estradiol to estrogen receptors (ERs) activates the homodimers of ER-DNA and its binding to estrogen response elements in the promoter region of genes such as neuronal nitric oxide synthase (NOS1) for regulating gene expression in target brain cells. In addition to the induction of NOS1, estrogen increases the expression of antiapoptotic protein such as bcl-2. Furthermore, our recent observations provide new molecular biologic and pharmacologic evidence suggesting that physiologic concentrations of 17β-estradiol (<10 nM) activate ERs (ERβ > ERα) and upregulate a cyclic guanosine 5′-monophosphate (cGMP)-dependent thioredoxin (Trx) and MnSOD expression following the induction of NOS1 in human brain-derived SH-SY5Y cells. We thus proposed that the estrogen-mediated gene induction of Trx plays a pivotal role in the promotion of neuroprotection because Trx is a multifunctional antioxidative and antiapoptotic protein. For managing progressive neurodegeneration such as Alzheimer dementia, our estrogen proposal of the signaling pathway of cGMP-dependent protein kinase (PKG) in mediating estrogen-induced cytoprotective genes thus fosters research and development of the new estrogen ligands devoid of female hormonal side effects such as carcinogenesis.

AB - The original neuroprotective hypothesis of estrogen was based on the gender difference in brain response to the ischemia-reperfusion injury. Additional clinical reports also suggest that estrogen may improve cognition in patients with Alzheimer disease. 17β-Estradiol is the most potent endogenous ligand of estrogen, which protects against neurodegeneration in both cell and animal models. Estrogen-mediated neuroprotection is probably mediated by both receptor-dependent and -independent mechanisms. Binding of estrogen such as 17β-estradiol to estrogen receptors (ERs) activates the homodimers of ER-DNA and its binding to estrogen response elements in the promoter region of genes such as neuronal nitric oxide synthase (NOS1) for regulating gene expression in target brain cells. In addition to the induction of NOS1, estrogen increases the expression of antiapoptotic protein such as bcl-2. Furthermore, our recent observations provide new molecular biologic and pharmacologic evidence suggesting that physiologic concentrations of 17β-estradiol (<10 nM) activate ERs (ERβ > ERα) and upregulate a cyclic guanosine 5′-monophosphate (cGMP)-dependent thioredoxin (Trx) and MnSOD expression following the induction of NOS1 in human brain-derived SH-SY5Y cells. We thus proposed that the estrogen-mediated gene induction of Trx plays a pivotal role in the promotion of neuroprotection because Trx is a multifunctional antioxidative and antiapoptotic protein. For managing progressive neurodegeneration such as Alzheimer dementia, our estrogen proposal of the signaling pathway of cGMP-dependent protein kinase (PKG) in mediating estrogen-induced cytoprotective genes thus fosters research and development of the new estrogen ligands devoid of female hormonal side effects such as carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0037606188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037606188&partnerID=8YFLogxK

U2 - 10.1385/ENDO:21:1:27

DO - 10.1385/ENDO:21:1:27

M3 - Review article

C2 - 12777700

AN - SCOPUS:0037606188

VL - 21

SP - 27

EP - 31

JO - Endocrine

JF - Endocrine

SN - 0969-711X

IS - 1

ER -